Dara Stein

Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study

Brian Bressler, Andrés Yarur, Mark S. Silverberg et al. · Journal of Crohn s and Colitis · 2021 · 147 citations · Full text

Pharmacy, Pharmacotherapy, Gastrointestinal Pharmacotherapy +16

Reduced Expression of Schwannomin/Merlin in Human Sporadic Meningiomas

Joung H. Lee, Vidyodhaya Sundaram, Dara Stein et al. · Neurosurgery · 1997 · 51 citations

Medicine, Neuroscience, Pathology +13

Treatment patterns and clinical outcomes with pazopanib in patients with advanced soft tissue sarcomas in a compassionate use setting: results of the SPIRE study

Hans Gelderblom, Ian Judson, Charlotte Benson et al. · Acta Oncologica · 2017 · 39 citations · Full text

Medicine, Oncology, Pharmacology +15

Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn’s disease patients: a German retrospective chart review

Ulf Helwig, Stefan Schubert, Heinz Hartmann et al. · BMC Gastroenterology · 2020 · 38 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +15

Dabrafenib plus trametinib is effective in the treatment of BRAF V600-mutated metastatic melanoma patients: analysis of patients from the dabrafenib plus trametinib Named Patient Program (DESCRIBE II)

Victoria Atkinson, Shahneen Sandhu, Geke A.P. Hospers et al. · Melanoma Research · 2020 · 36 citations · Full text

Medicine, Oncology, Pharmacotherapy +14